Development and Validation of a Mobile Application as an Adjuvant Treatment for People Diagnosed with Long COVID-19: Protocol... 2022 Samper-Pardo

Discussion in 'Long Covid research' started by Andy, Jan 9, 2023.

  1. Andy

    Andy Committee Member

    Messages:
    22,407
    Location:
    Hampshire, UK
    Full title: Development and Validation of a Mobile Application as an Adjuvant Treatment for People Diagnosed with Long COVID-19: Protocol for a Co-Creation Study of a Health Asset and an Analysis of Its Effectiveness and Cost-Effectiveness

    Abstract

    Objective: To analyse the overall effectiveness and cost-efficiency of a mobile application (APP) as a community health asset (HA) with recommendations and recovery exercises created bearing in mind the main symptoms presented by patients in order to improve their quality of life, as well as other secondary variables, such as the number and severity of ongoing symptoms, physical and cognitive functions, affective state, and sleep quality.

    Methods: The first step was to design and develop the technologic community resource, the APP, following the steps involved in the process of recommending health assets (RHA). After this, a protocol of a randomised clinical trial for analysing its effectiveness and cost-efficiency as a HA was developed. The participants will be assigned to: (1st) usual treatment by the primary care practitioner (TAU), as a control group; and (2nd) TAU + use of the APP as a HA and adjuvant treatment in their recovery + three motivational interviews (MI), as an interventional group. An evaluation will be carried out at baseline with further assessments three and six months following the end of the intervention.

    Discussion: Although research and care for these patients are still in their initial stages, it is necessary to equip patients and health care practitioners with tools to assist in their recovery. Furthermore, enhanced motivation can be achieved through telerehabilitation (TR).

    Open access, https://www.mdpi.com/1660-4601/20/1/462
     
    Peter Trewhitt likes this.
  2. Trish

    Trish Moderator Staff Member

    Messages:
    53,666
    Location:
    UK
    'recovery exercises' and 'motivational interviews'... really? What could possibly go wrong?
    Surely the 'first step' is not to develop and app, but to find out whether there is any treatment sufficiently useful to put on the app.
     
  3. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    13,008
    Location:
    Canada
    Everything has been stuck at this infantile stage because of the mindless obsession that this is a problem of motivation or whatever it is think is happening here. This junk is literally the whole reason. Even when those programs fail everyone seems to applaud themselves anyway. Even in the first SARS epidemic they did the same, the rehabilitation had no positive impact and they still framed it as necessary. Absurd.
    Somehow, one of the references for this is an article about NICE overturning this recommendation.
    References for this are just temporary speculative guidelines that recommend the same without evidence. Thanks to the mindless process of saying that rehabilitation should work, without evidence, now people can simply cite papers saying so, even though they have no evidence. The asymmetry of bullshit, turbocharged. Literally bootstrapped evidence, supporting itself hovering above hot air.

    The entire system is not working out here. Medical academia is completely incapable of doing this, it's just mindless nonsense on repeat that simply pays no attention to reality or outcomes. The process needs to be opened up, gutted inside out, and rebuilt in a process that benefits patient outcomes, whereas right now it's entirely irrelevant.
     
    alktipping and Peter Trewhitt like this.
  4. Sean

    Sean Moderator Staff Member

    Messages:
    7,608
    Location:
    Australia
    three motivational interviews

    Sean's Rule: Any treatment using the word 'motivational' or similar is not science based.
     

Share This Page